Venous and arterial thrombosis in patients with VEXAS syndrome
Yael Kusne(WinnMed), Emma M. Groarke(MACOM (United States)), Matthew J. Koster(Mayo Clinic in Arizona), Damon E. Houghton(Mayo Clinic), Horatiu Olteanu(Mayo Clinic in Arizona), Ronald S. Go(Mayo Clinic), Daniel L. Kastner(National Institutes of Health), Alexander Hines(WinnMed), Kaitlin A. Quinn, Terra Lasho(Mayo Clinic), Katherine R. Calvo(National Institutes of Health Clinical Center), Kenneth J. Warrington(Mayo Clinic), Lorena Wilson(National Institutes of Health), David B. Beck(Center for Human Genetics), Pedro E. Alcedo(National Institutes of Health), Ruba Shalhoub(National Heart Lung and Blood Institute), Amanda K. Ombrello(National Human Genome Research Institute), Raul C. Braylan(Center for Cancer Research), Yogendra Kanthi(National Heart Lung and Blood Institute), Sumith R. Panicker(Unknown), Neal S. Young(National Heart Lung and Blood Institute), Mrinal M. Patnaik(Mayo Clinic), Jibran Durrani(National Institutes of Health), Colin O. Wu(National Heart Lung and Blood Institute), Ivana Darden(National Heart Lung and Blood Institute), Kaaren K. Reichard(Mayo Clinic), Bhavisha A. Patel(MACOM (United States)), Marcela A. Ferrada(University of Maryland, Baltimore), Peter C. Grayson(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Ana I. Casanegra(Mayo Clinic), Wendy Goodspeed(National Institutes of Health), Alina Dulau-Florea(National Institutes of Health), Atefeh Ghorbanzadeh(Mayo Clinic), Khanh Nghiem(National Institutes of Health Clinical Center), Abhishek A. Mangaonkar(Mayo Clinic)
Cited by 55
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k